In June 2024, the U.S. Food and Drug Administration (FDA) approved the first chewable tablets developed to help manage urinary incontinence in dogs caused by urethral sphincter hypotonus. Produced by ...

The "Canine Oral Chewable Tablets Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The canine oral chewable tablets market is evolving as pet owner ...

If you're a dog or cat owner, you know they are not ticks-free. If you're unaware, a disease can carry over humans through these parasites. While there are medications for Lyme disease, the same ...

Launches of Tuzulby® methylphenidate prolonged-release chewable tablets and Paxneury® guanfacine prolonged-release tablets, also in 5mg, 6mg, and 7mg strengthsTwo differentiated treatments exemplify ...